Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 10/20 | 0.42 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.39 |
| ▸ | KDM4A | O75164 | 1/20 | 0.36 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | HRH1 | P35367 | 1/20 | 0.34 |
| ▸ | ALB | P02768 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19401625 | 1.00 | CPB2 (0.43) | CPB2FOLH1KISS1RKDM4AKDM4C | |
| SCHEMBL13057114 | 1.00 | CPB2 (0.43) | CPB2FOLH1KISS1RKDM4AKDM4C | |
| SCHEMBL22100977 | 0.94 | KISS1R (0.44) | CPB2FOLH1KISS1RKDM4AKDM4C | |
| SCHEMBL13323375 | 0.94 | KISS1R (0.44) | CPB2FOLH1KISS1RKDM4AKDM4C | |
| SCHEMBL12890791 | 0.94 | KISS1R (0.44) | CPB2FOLH1KISS1RKDM4AKDM4C | |
| SCHEMBL3438650 | 0.86 | CPB2 (0.42) | CPB2FOLH1KISS1RKDM4AKDM4C | |
| SCHEMBL15393668 | 0.86 | FOLH1 (0.43) | CPB2FOLH1KISS1RSMN1; SMN2NOD1 | |
| SCHEMBL29187495 | 0.85 | FOLH1 (0.35) | CPB2FOLH1KISS1RSMN1; SMN2HTR2A | |
| SCHEMBL14002511 | 0.85 | FOLH1 (0.35) | CPB2FOLH1KISS1RSMN1; SMN2HTR2A | |
| SCHEMBL25476072 | 0.84 | FOLH1 (0.41) | FOLH1SMN1; SMN2NOD1ALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | claimed |
| US-20110064668-A1 | J-SUPERFAMILY CONOTOXIN PEPTIDES | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2011-03-17 | — | — | US | claimed |
| US-20100093620-A1 | TYROSINE-RICH CONOPEPTIDES | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2010-04-15 | — | — | US | claimed |
| WO-2007145987-A1 | J-SUPERFAMILY CONOTOXIN PEPTIDES | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2007-12-21 | — | — | WO | claimed |
| US-20060205656-A1 | P-superfamily conopeptides | COGNETIX, INC. (US) | 2006-09-14 | — | — | US | claimed |
| US-20050143560-A1 | Polypeptide analgesics from snail venom; analogous to the naturally available peptides, and which preferably include two disulfide bonds | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2005-06-30 | — | — | US | claimed |
| US-20050096270-A1 | I-superfamily conotoxins | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2005-05-05 | — | — | US | claimed |
| US-20040259794-A1 | MuO-conopeptides and their use as local anesthetics | COGNETIX, INC. (US) | 2004-12-23 | — | — | US | claimed |
| EP-1307215-A4 | I-SUPERFAMILY CONOTOXINS | UNIV UTAH RES FOUND (US) | 2004-09-08 | — | — | EP | claimed |
| EP-1185286-A4 | MU O-CONOPEPTIDES AND THEIR USE AS LOCAL ANESTHETICS | UNIV UTAH RES FOUND (US) | 2004-09-08 | — | — | EP | claimed |
| US-6767896-B1 | POLYPEPTIDE ANALGESICS FROM SNAIL VENOM | COGNETIX, INC. | 2004-07-27 | — | — | US | claimed |
| US-6767895-B2 | PEPTIDE FOR USE IN THE TREATMENT OF PAIN, STROKE, NERVOUS SYSTEM DISORDERS, MULTIPLE SCLEROSIS, HUNTINGTON'S CHOREA, FOOD POISONING, CARDIOVASCULAR DISORDERS, DRUG ADDICTION, MUSCULAR DISORDERS, EPILEPSY | COGNETIX, INC. | 2004-07-27 | — | — | US | claimed |
| US-20030166560-A1 | Snail/mollusc polypeptides; anticonvulsant drug screening | HOOPER DAVID (US) | 2003-09-04 | — | — | US | claimed |
| EP-1307215-A2 | I-SUPERFAMILY CONOTOXINS | The University of Utah Research Foundation (US) | 2003-05-07 | — | — | EP | claimed |
| US-20020198145-A1 | MuO-conopeptides and their use as local anesthetics | COGNETIX, INC. (US) | 2002-12-26 | — | — | US | claimed |
| US-20020102607-A1 | I-superfamily conotoxins | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2002-08-01 | — | — | US | claimed |
| EP-1185286-A1 | MU O-CONOPEPTIDES AND THEIR USE AS LOCAL ANESTHETICS | The University of Utah Research Foundation (US) | 2002-03-13 | — | — | EP | claimed |
| WO-2002002590-A2 | I-SUPERFAMILY CONOTOXINS | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2002-01-10 | — | — | WO | claimed |
| WO-2001035985-A1 | P-SUPERFAMILY CONOPEPTIDES | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2001-05-25 | — | — | WO | claimed |
| WO-2000076532-A1 | νO-CONOPEPTIDES AND THEIR USE AS LOCAL ANESTHETICS | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2000-12-21 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110064668-A1 | J-SUPERFAMILY CONOTOXIN PEPTIDES | KCNQ1, KCNQ2, KCNA3 | CPB2 2492/4885FOLH1 2259/4885KISS1R 80/4885 |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | CPB2 1133/4885FOLH1 1381/4885KISS1R 4361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.